非特定条件的临床试验
总计437600个结果
-
Alliance for Clinical Trials in OncologyNational Cancer Institute (NCI)完全的
-
Abramson Cancer Center of the University of PennsylvaniaNational Cancer Institute (NCI)完全的
-
Memorial Sloan Kettering Cancer CenterNational Cancer Institute (NCI)完全的
-
Genentech, Inc.National Cancer Institute (NCI); Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins完全的
-
Southwest Oncology GroupNational Cancer Institute (NCI)撤销未明确的成人实体瘤,特定方案
-
National Cancer Institute (NCI)完全的
-
Children's Oncology GroupNational Cancer Institute (NCI)完全的
-
National Cancer Institute (NCI)完全的
-
H. Lee Moffitt Cancer Center and Research InstituteNational Cancer Institute (NCI)未知
-
Institute of Cancer Research, United KingdomNational Cancer Institute (NCI)未知
-
Memorial Sloan Kettering Cancer CenterNational Cancer Institute (NCI)完全的
-
Memorial Sloan Kettering Cancer CenterNational Cancer Institute (NCI)完全的
-
Memorial Sloan Kettering Cancer CenterNational Cancer Institute (NCI)完全的
-
National Cancer Institute (NCI)完全的
-
National Cancer Institute (NCI)完全的
-
Cancer Research UK完全的
-
Memorial Sloan Kettering Cancer CenterNational Cancer Institute (NCI)完全的
-
Dale Shepard, MD, PhDNational Cancer Institute (NCI)终止
-
National Cancer Institute (NCI)完全的未明确的儿童实体瘤,具体方案美国, 加拿大
-
Ohio State University Comprehensive Cancer CenterNational Cancer Institute (NCI)完全的
-
National Cancer Institute (NCI)完全的
-
National Cancer Institute (NCI)完全的
-
Memorial Sloan Kettering Cancer CenterNational Cancer Institute (NCI)完全的
-
National Cancer Institute (NCI)完全的
-
St. Jude Children's Research HospitalNational Cancer Institute (NCI)完全的
-
European Organisation for Research and Treatment...完全的
-
European Organisation for Research and Treatment...暂停
-
European Organisation for Research and Treatment...撤销
-
European Organisation for Research and Treatment...完全的
-
UNC Lineberger Comprehensive Cancer CenterNational Cancer Institute (NCI)完全的
-
University of California, DavisBristol-Myers Squibb; National Cancer Institute (NCI); Genentech, Inc.终止
-
Hoag Memorial Hospital PresbyterianCancer Biotherapy Research Group完全的
-
Proacta, Incorporated完全的
-
Case Comprehensive Cancer CenterNational Cancer Institute (NCI)完全的
-
City of Hope Medical CenterNational Cancer Institute (NCI)完全的
-
Memorial Sloan Kettering Cancer CenterNational Cancer Institute (NCI)完全的
-
University of WashingtonGenentech, Inc.暂停原发性纵隔(胸腺)大 B 细胞淋巴瘤 | 侵袭性非霍奇金淋巴瘤 | 弥漫性大 B 细胞淋巴瘤,未另行说明 | EBV 阳性弥漫性大 B 细胞淋巴瘤,未另行说明 | 高级 B 细胞淋巴瘤,未另行说明 | 富含 T 细胞/组织细胞的大 B 细胞淋巴瘤 | ALK 阳性大 B 细胞淋巴瘤 | B 细胞淋巴瘤,无法分类,具有介于弥漫性大 B 细胞淋巴瘤和经典霍奇金淋巴瘤之间的特征 | 具有 MYC 和 BCL2 和/或 BCL6 重排的高级别 B 细胞淋巴瘤美国